Overview
Doctronic is a health-technology company operating an AI chatbot for prescription refill facilitation under Utah’s regulatory sandbox. The pilot tests whether AI can streamline maintenance medication renewals while maintaining physician oversight.
Utah Pilot (2026)
- Launch: January 2026 under Utah Office of Artificial Intelligence Policy (OAIP) regulatory mitigation agreement
- Phase 1 (current): 100% human physician review of every AI-generated refill before pharmacy transmission (2026-07-06-utah-doctronic-official)
- Scope: 192 maintenance medications; 30/60/90-day renewals only; no new prescriptions or controlled substances
- Opposition: Utah medical board called for suspension; FDA has not authorized any AI chatbot for prescriptions (2026-07-06-utah-doctronic-ap-news)
Doctronic's efficacy data is company-authored, not independently peer-reviewed. Phase 3 semi-autonomous refills are planned but not live.
Expansion
Similar pilots advancing in Texas, Wyoming, and Cicero Institute-backed bills in other states (2026-07-06-utah-ai-prescription-refill-doctronic).